Shared ligand-blocking mechanism but distinct conformational modulation by α5-targeting antibodies BIIG2 and MINT1526A
Structure · 2026
DOI: 10.1016/j.str.2026.08.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Structure, 2026. Verfasst von Adam Nguyen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Biological Physics Structure and Design Program, University of Washin…. Hauptthemen laut MEDLINE: Integrin alpha5beta1. Die Arbeit nennt 139 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Integrins are heterodimeric receptors important for cell adhesion and signaling. Integrin α5β1 is a key mediator of angiogenesis and its dysregulation is associated with tumor progression and metastasis. Despite numerous efforts, α5β1-targeting therapeutics have been unsuccessful due to poor efficacy and off-target effects. A contributing factor is our limited understanding of how integrin conformation influences interactions with therapeutics. Using cell-based functional assays, patient-derived xenografts, biophysics, X-ray crystallography, and electron microscopy, we shed light on these relationships by characterizing two anti-α5β1 antibodies, BIIG2 and MINT1526A. We show that both antibodies bind α5β1 with nanomolar affinity, reduce tube formation in vitro, and bind overlapping epitopes that block fibronectin binding. However, using electron microscopy, we reveal that while BIIG2 binding does not substantially alter the conformational states, MINT1526A preferentially recognizes the bent conformation and restricts the conformational ensemble. These insights can guide which aspects to prioritize to improve the design of future integrin-targeted therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Biological Physics Structure and Design Program, University of Washington, Seattle, WA 98195, USA.
- Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA; Department of Chemistry, University of Oslo, 0315 Oslo, Norway.
- Department of Chemistry, University of Oslo, 0315 Oslo, Norway.
- Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
- Medical Genome Facility, Proteomics Core, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA.
Förderung
- NIGMS NIH HHS
- NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- Mayo Clinic Arizona
- The Pew Charitable Trusts
- National Institutes of Health National Cancer Institute
Zitieren
APA
Nguyen, A., Heim, J. B., Cordara, G., Chan, M. C., Johannesen, H., Charlesworth, C., Li, M., Azumaya, C. M., Madden, B., Krengel, U., Meves, A., & Campbell, M. G. (2026). Shared ligand-blocking mechanism but distinct conformational modulation by α5-targeting antibodies BIIG2 and MINT1526A. Structure. https://doi.org/10.1016/j.str.2026.08.001
Vancouver
Nguyen A, Heim JB, Cordara G, Chan MC, Johannesen H, Charlesworth C, et al. Shared ligand-blocking mechanism but distinct conformational modulation by α5-targeting antibodies BIIG2 and MINT1526A. Structure. 2026. doi:10.1016/j.str.2026.08.001
BibTeX
@article{Nguyen2026,
author = {Nguyen, Adam and Heim, Joel B and Cordara, Gabriele and Chan, Matthew C and Johannesen, Hedda and Charlesworth, Cristine and Li, Ming and Azumaya, Caleigh M and Madden, Benjamin and Krengel, Ute and Meves, Alexander and Campbell, Melody G},
title = {Shared ligand-blocking mechanism but distinct conformational modulation by α5-targeting antibodies BIIG2 and MINT1526A},
journal = {Structure},
year = {2026},
doi = {10.1016/j.str.2026.08.001}
}
EUVIMED